John T Schiller Selected Research

Uterine Cervical Neoplasms (Cancer of the Cervix)

12/2023	An HPV vaccine from India: broadening possibilities for cervical cancer control.
1/2022	Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022.
1/2022	Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.
12/2020	Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.
1/2018	Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins.
1/2017	Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism.
1/2014	Virus infection and human cancer: an overview.
12/2013	Comprehensive control of human papillomavirus infections and related diseases.
12/2013	Comprehensive control of human papillomavirus infections and related diseases.
12/2013	Comprehensive control of human papillomavirus infections and related diseases.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John T Schiller Research Topics

Disease

66	Infections 02/2024 - 03/2003
39	Neoplasms (Cancer) 11/2023 - 07/2003
39	Papillomavirus Infections 10/2022 - 07/2003
28	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2023 - 07/2003
10	Uterine Cervical Dysplasia 01/2022 - 08/2006
7	Persistent Infection 01/2022 - 05/2006
4	Papilloma (Papillomatosis) 01/2020 - 12/2013
4	Condylomata Acuminata (Genital Wart) 06/2013 - 05/2006
3	Wounds and Injuries (Trauma) 01/2022 - 12/2009
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2019 - 12/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2023 - 05/2023
2	Virus Diseases (Viral Diseases) 05/2011 - 09/2010
1	COVID-19 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Uveal melanoma 01/2018
1	Non-Muscle Invasive Bladder Neoplasms 07/2016
1	Hypersensitivity (Allergy) 04/2016
1	Noncommunicable Diseases 04/2016
1	Malaria 04/2016
1	Lung Neoplasms (Lung Cancer) 02/2016
1	Spontaneous Abortion (Miscarriage) 09/2015
1	Typhoid Fever (Typhoid) 05/2015
1	Measles 05/2015
1	Warts (Wart) 06/2014
1	Oropharyngeal Neoplasms 01/2013
1	Vesicular Stomatitis 01/2012
1	Reinfection 06/2009
1	Carcinoma (Carcinomatosis) 05/2009
1	Vulvovaginal Candidiasis 08/2008

Drug/Important Bio-Agent (IBA)

65	VaccinesIBA 11/2023 - 07/2003
21	Papillomavirus Vaccines (HPV Vaccines)IBA 12/2023 - 04/2004
15	AntibodiesIBA 02/2024 - 07/2003
13	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2004
10	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2003
8	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2022 - 12/2008
7	Capsid Proteins (Capsid Protein)IBA 01/2017 - 07/2003
7	Neutralizing AntibodiesIBA 12/2012 - 07/2003
5	AntigensIBA 01/2018 - 07/2003
4	Combined VaccinesIBA 01/2022 - 12/2014
4	Peptides (Polypeptides)IBA 01/2022 - 04/2004
4	CarrageenanIBA 02/2016 - 07/2006
4	18 L1 type 16 human papillomavirus vaccine (Cervarix)IBA 06/2014 - 08/2008
4	FurinIBA 06/2010 - 01/2006
3	EpitopesIBA 01/2022 - 05/2008
3	Antiviral Agents (Antivirals)IBA 01/2021 - 09/2006
3	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 03/2009
3	18 16 11 Types 6 Human Papillomavirus Recombinant Vaccine Quadrivalent (Gardasil)FDA Link 06/2014 - 08/2008
3	Heparitin Sulfate (Heparan Sulfate)IBA 03/2009 - 07/2006
2	LDL CholesterolIBA 09/2023 - 05/2023
2	oxidized low density lipoproteinIBA 09/2023 - 05/2023
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 01/2018
2	Coloring Agents (Dyes)IBA 01/2022 - 01/2018
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2012
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 10/2011
2	Viral DNAIBA 01/2019 - 08/2007
2	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 04/2008
2	LuciferasesIBA 06/2014 - 11/2012
2	Cell Surface ReceptorsIBA 06/2010 - 12/2008
2	heparitinsulfate lyaseIBA 12/2009 - 03/2009
2	Polysaccharides (Glycans)IBA 07/2007 - 07/2006
2	Immunoglobulin G (IgG)IBA 05/2005 - 04/2004
1	Poly CIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Chondroitin Sulfate ProteoglycansIBA 01/2022
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2022
1	AcidsIBA 01/2022
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2022
1	CalreticulinIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2017
1	CytokinesIBA 01/2017
1	Thymidine KinaseIBA 07/2016
1	ProdrugsIBA 07/2016
1	Ganciclovir (Cytovene)FDA LinkGeneric 07/2016
1	AutoantigensIBA 04/2016
1	Indicators and Reagents (Reagents)IBA 02/2016
1	Virus-Like Particle VaccinesIBA 01/2016
1	Hepatitis A Vaccines (Hepatitis A Vaccine)IBA 09/2015
1	Attenuated VaccinesIBA 05/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2014
1	CarcinogensIBA 08/2014
1	LigandsIBA 06/2014
1	FlagellinIBA 06/2014
1	Complement System Proteins (Complement)IBA 01/2012
1	phenylmercury borateIBA 05/2011
1	Proprotein Convertase 5IBA 12/2009
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 12/2009
1	GPI0100IBA 06/2009
1	Phosphates (Orthophosphate)IBA 06/2009
1	aluminum sulfate (alum)IBA 06/2009
1	1018 oligonucleotideIBA 06/2009
1	Peptide Hydrolases (Proteases)FDA Link 12/2008
1	AzolesIBA 08/2008

Therapy/Procedure

4	Therapeutics 01/2022 - 08/2007
3	Immunotherapy 01/2022 - 07/2016
2	Intravenous Injections 01/2021 - 02/2016
2	Aftercare (After-Treatment) 01/2021 - 01/2016
2	Secondary Prevention 10/2008 - 08/2006
1	Drug Tapering 10/2022
1	Intramuscular Injections 06/2010